Evidence map›Paper›PMID 25918553›Full record

ArticleGenome medicine2015

Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis.

Susan Yost, Ana E Duran-Pinedo, Ricardo Teles, Keerthana Krishnan, Jorge Frias-Lopez

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Genome medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01489839 (Biomarkers of Periodontal Disease Progression), which is not on this map. Cited by 202 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed, 3 pooled it
27.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01489839 completednot on this map

Biomarkers of Periodontal Disease Progression

TypeobservationalSponsorThe Forsyth InstituteRan2012 to 2017Enrolled157ConditionsPeriodontal DiseaseArmsPeriodontal therapy
3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 3 syntheses or guidelines pooled it, 337 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Susan YostForsyth Institute, 245 First Street, Cambridge, Massachusetts 02142 USA.
Ana E Duran-PinedoForsyth Institute, 245 First Street, Cambridge, Massachusetts 02142 USA.
Ricardo TelesUniversity of North Carolina Chapel Hill, School of Dentistry, Chapel Hill, NC 27599-7450 USA.
Keerthana KrishnanForsyth Institute, 245 First Street, Cambridge, Massachusetts 02142 USA.
Jorge Frias-LopezForsyth Institute, 245 First Street, Cambridge, Massachusetts 02142 USA ; Harvard School of Dental Medicine, 188 Longwood Ave, Boston, MA 02115 USA.
Health First · USMassachusetts Institute of Technology · USUniversity of North Carolina at Chapel Hill · US

Funding

Biomarkers of Periodontal Disease ProgressionU01DE021127 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI TELES, RICARDO P · 2010 to 2016
$16.2M
Metatramscriptome of the Oral Microbiome During Periodontal Disease ProgressionR01DE021553 · NIDCR · UNIVERSITY OF FLORIDA · PI FRIAS-LOPEZ, JORGE · 2010 to 2020
$4.3M
NIDCR NIH HHS R01 DE021553NIDCR NIH HHS U01 DE021127
6 · The paper itself

Abstract

backgroundPeriodontitis is a polymicrobial biofilm-induced inflammatory disease that affects 743 million people worldwide. The current model to explain periodontitis progression proposes that changes in the relative abundance of members of the oral microbiome lead to dysbiosis in the host-microbiome crosstalk and then to inflammation and bone loss. Using combined metagenome/metatranscriptome analysis of the subgingival microbiome in progressing and non-progressing sites, we have characterized the distinct molecular signatures of periodontitis progression.

methodsMetatranscriptome analysis was conducted on samples from subgingival biofilms from progressing and stable sites from periodontitis patients. Community-wide expression profiles were obtained using Next Generation Sequencing (Illumina). Sequences were aligned using 'bowtie2' against a constructed oral microbiome database. Differential expression analysis was performed using the non-parametric algorithm implemented on the R package 'NOISeqBio'. We summarized global functional activities of the oral microbial community by set enrichment analysis based on the Gene Ontology (GO) orthology.

resultsGene ontology enrichment analysis showed an over-representation in the baseline of active sites of terms related to cell motility, lipid A and peptidoglycan biosynthesis, and transport of iron, potassium, and amino acids. Periodontal pathogens (Tannerella forsythia and Porphyromonas gingivalis) upregulated different TonB-dependent receptors, peptidases, proteases, aerotolerance genes, iron transport genes, hemolysins, and CRISPR-associated genes. Surprisingly, organisms that have not been usually associated with the disease (Streptococcus oralis, Streptococcus mutans, Streptococcus intermedius, Streptococcus mitis, Veillonella parvula, and Pseudomonas fluorenscens) were highly active transcribing putative virulence factors. We detected patterns of activities associated with progression of clinical traits. Among those we found that the profiles of expression of cobalamin biosynthesis, proteolysis, and potassium transport were associated with the evolution towards disease.

conclusionsWe identified metabolic changes in the microbial community associated with the initial stages of dysbiosis. Regardless of the overall composition of the community, certain metabolic signatures are consistent with disease progression. Our results suggest that the whole community, and not just a handful of oral pathogens, is responsible for an increase in virulence that leads to progression.

trial registrationNCT01489839, 6 December 2011.

Identifiers

PMID25918553
PMCPMC4410737
OpenAlexW2171961740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.